Market
Novanta outlays $1.45bn for Riverpoint Medical buyout
Novanta announced the acquisition of Riverpoint Medical for $1.45 billion. The deal expands Novanta's footprint into minimally invasive surgery and strengthens its medical consumables portfolio, representing a significant strategic move to broaden its surgical and procedural device offerings.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network